Description
P56 Tolerability of a plasma-derived von Willebrand factor (VWF) concentrate (WILFACTIN): more than 15 years of clinical development in patients with inherited von Willebrand disease
Article: P56 Tolerability of a plasma-derived von Willebrand factor (VWF) concentrate (WILFACTIN): more than 15 years of clinical development in patients with inherited von Willebrand disease
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
Article: Calendar of events
€2.42 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€147.15 Add to cart
